Answer
Women must not breastfeed during sorafenib tosilate treatment because it could harm infant growth and development, although whether sorafenib is excreted in human milk is unknown.
Sources for this answer
- Nexavar 200mg film-coated tabletsBayer plc · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 32Document updated
Sources checked